skip to main content

Prof. Webster Santos and team receive $1.2 million to research compounds to treat fatty liver disease

Webster Santos

(August 15, 2018) Professor Webster Santos, along with collaborator Prof. Kyle Hoehn in the Department of Pharmacology at the University of Virginia, received a $400K grant from the Virginia Biosciences Health Research Corporation (VBHRC) with $800K in matching funds from Contiuum Biosciences. The grant and the matching funds will support Santos and Hoehn's research to develop drugs to treat nonalcoholic steatohepatitis (NASH), a type of nonalcoholic fatty liver disease.

Click here to read the full VT News article about the grant and the research it will support